Jump Financial’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
Jump Financial's CTKB Position: Q3 2026 in Review
Jump Financial reduced its Cytek Biosciences (CTKB) stake by 47% in Q3 2026, selling an estimated $333K and leaving 77,930 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.
Jump Financial first reported a position in CTKB in Q1 2022 and has held it in 8 quarters since. The position peaked at $911K in Q1 2023. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- Jump Financial held 77,930 shares of Cytek Biosciences worth $464K as of Q3 2026.
- Jump Financial sold 70,153 Cytek Biosciences shares in Q3 2026, an estimated $333K.
- Cytek Biosciences made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #1734 holding.
- Jump Financial first reported a position in Cytek Biosciences in Q1 2022 and has held it in 8 quarters since.
- Jump Financial's Cytek Biosciences position peaked at $911K in Q1 2023.
- 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.